Posted by Chantel M. Research contributed by the US National Library of Medicine National Institutes of Health
The prevalence of childbearing age obesity is wide spreading in US,
approximately, 50% of them are either overweight [body mass index (BMI)
25-29.9 kg/m(2)] or obese (BMI ≥ 30 kg/m(2)).
Polycystic ovary syndrome: impact on metabolism and fertility
Obesity is frequently present in patients with polycystic ovary syndrome
(PCOS) and plays an important role in the pathogenesis of the
metabolic, endocrine, and reproductive abnormalities associated with
this syndrome. In the study to to summarize the effects of lifestyle changes and anti-obesity pharmacotherapy in patients with PCOS, by reviewing the literature regarding the effects of lifestyle changes and anti-obesity
agents on the metabolic and endocrine abnormalities of PCOS. Lifestyle
changes, including diet, exercise, and behavioral modification, appear
to improve the metabolic and reproductive abnormalities of overweight
and obese patients with PCOS, posted in PubMed,
indicated that lifestyle changes appear to represent the first-line
management for all overweight and obese patients with PCOS. However, the
optimal composition of diet and the optimal type of exercise in these
patients are unknown. Anti-obesity agents
that have been studied in PCOS include orlistat, sibutramine, and
rimonabant. However, the latter two agents have been withdrawn from the
market because of side effects. Long-term studies with orlistat in
overweight and obese diabetic patients showed greater weight loss and
metabolic and cardiovascular benefits than those achieved with lifestyle
changes alone.
Chinese Secrets to Fatty Liver and Obesity Reversal
For more information and health articles, please visit women's health http://thetruestoriesstories.blogspot.ca/
No comments:
Post a Comment